MXPA03005981A - Antagonistas de receptores de aminoacidos excitatorios. - Google Patents

Antagonistas de receptores de aminoacidos excitatorios.

Info

Publication number: MXPA03005981A
Authority: MX; Mexico
Prior art keywords: amino acid; receptor antagonists; acid receptor; excitatory amino; excitatory
Prior art date: 2001-01-05

Application number

MXPA03005981A

Other languages

English (en)

Inventor

John Martinelli Michael

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-05

Filing date

2001-12-20

Publication date

2003-09-10

2001-12-20 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2003-09-10 Publication of MXPA03005981A publication Critical patent/MXPA03005981A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

MXPA03005981A 2001-01-05 2001-12-20 Antagonistas de receptores de aminoacidos excitatorios. MXPA03005981A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US26001401P	2001-01-05	2001-01-05
PCT/US2001/044715 WO2002053561A1 (en)	2001-01-05	2001-12-20	Excitatory amino acid receptor antagonists

Publications (1)

Publication Number	Publication Date
MXPA03005981A true MXPA03005981A (es)	2003-09-10

Family

ID=22987455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03005981A MXPA03005981A (es)	2001-01-05	2001-12-20	Antagonistas de receptores de aminoacidos excitatorios.

Country Status (23)

Country	Link
EP (1)	EP1351955A1 (es)
JP (1)	JP2004520335A (es)
KR (1)	KR20030066797A (es)
CN (1)	CN1484642A (es)
AR (1)	AR035679A1 (es)
BR (1)	BR0116672A (es)
CA (1)	CA2431545A1 (es)
CZ (1)	CZ20031856A3 (es)
DZ (1)	DZ3460A1 (es)
EA (1)	EA200300770A1 (es)
EC (1)	ECSP034682A (es)
HR (1)	HRP20030544A2 (es)
HU (1)	HUP0302528A2 (es)
IL (1)	IL156138A0 (es)
MX (1)	MXPA03005981A (es)
NO (1)	NO20032973L (es)
NZ (1)	NZ525821A (es)
PE (1)	PE20020792A1 (es)
PL (1)	PL361934A1 (es)
SK (1)	SK8242003A3 (es)
TW (1)	TW591023B (es)
WO (1)	WO2002053561A1 (es)
ZA (1)	ZA200304311B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5284957A (en) *	1992-09-03	1994-02-08	Eli Lilly And Company	Excitatory amino acid receptor antagonists
CA2319652A1 (en) *	1998-02-06	1999-08-12	Michael Urquhart	Salts of paroxetine
GB9908175D0 (en) *	1999-04-09	1999-06-02	Lilly Co Eli	Method of treating neurological disorders
IL146697A0 (en) *	1999-07-06	2002-07-25	Lilly Co Eli	SELECTIVE iGluR5 RECEPTOR FOR THE TREATMENT OF MIGRAINE

2001
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Withdrawn
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
2002
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973L/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown

Also Published As

Publication number	Publication date
WO2002053561A1 (en)	2002-07-11
HRP20030544A2 (en)	2004-08-31
DZ3460A1 (fr)	2002-07-11
NO20032973D0 (no)	2003-06-27
JP2004520335A (ja)	2004-07-08
IL156138A0 (en)	2003-12-23
CA2431545A1 (en)	2002-07-11
TW591023B (en)	2004-06-11
BR0116672A (pt)	2003-09-23
CZ20031856A3 (cs)	2003-09-17
EP1351955A1 (en)	2003-10-15
AR035679A1 (es)	2004-06-23
KR20030066797A (ko)	2003-08-09
ZA200304311B (en)	2004-09-02
EA200300770A1 (ru)	2003-10-30
NO20032973L (no)	2003-06-27
PL361934A1 (en)	2004-10-18
HUP0302528A2 (hu)	2003-11-28
PE20020792A1 (es)	2002-09-06
NZ525821A (en)	2004-07-30
SK8242003A3 (en)	2004-01-08
CN1484642A (zh)	2004-03-24
ECSP034682A (es)	2003-08-29

Publication	Publication Date	Title
IL165841A0 (en)	2006-01-15	Mchir antagonists
PL374017A1 (en)	2005-09-19	Calcitonin gene related peptide receptor antagonists
HUP0303730A2 (en)	2006-02-28	Disease-associated protein
MXPA03007869A (es)	2003-12-04	Inhibidores peptidicos de desformilasa.
AP2004003156A0 (en)	2004-12-31	Peptide deformylase inhibitors.
EP1359915A4 (en)	2004-07-21	UROTENSIN-II RECEPTOR ANTAGONISTS
PL362838A1 (en)	2004-11-02	Somatostatin antagonists
ZA956812B (en)	1997-02-17	Excitatory amino acid receptor antagonists.
MXPA03005982A (es)	2003-09-10	Antagonistas de receptores de aminoacidos excitadores.
MXPA03006408A (es)	2003-10-15	Antagonistas de receptores de histamina.
PL370367A1 (en)	2005-05-16	Ccr-3 receptor antagonists v
MXPA03005981A (es)	2003-09-10	Antagonistas de receptores de aminoacidos excitatorios.
MX258179B (es)	2008-06-25	Poliamidas.
AU2002227020A1 (en)	2002-07-16	Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
HK1060350A (en)	2004-08-06	Excitatory amino acid receptor antagonists
AU2002228736A1 (en)	2002-07-16	Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
MXPA03009930A (es)	2004-01-29	Antagonistas del receptor del factor liberador de corticotropina.
AU6455501A (en)	2001-12-11	Excitatory amino acid receptor modulators
GB0128161D0 (en)	2002-01-16	Receptor protein
AU2003219955A1 (en)	2003-10-13	Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
AU2001264554A1 (en)	2001-12-11	Excitatory amino acid receptor modulators
AU2003212418A8 (en)	2003-09-02	Peptide deformylase
GB0223877D0 (en)	2002-11-20	Receptor proteins
GB0220459D0 (en)	2002-10-09	Receptor proteins
AU2002235453A1 (en)	2002-08-06	Urotensin-ii receptor antagonists